Bengaluru-primarily based health diagnostic business enterprise Acculi Labs on Monday introduced that it had raised Rs five crore (about $700,000) in a seed investment spherical from PirE Ventures, an funding company primarily based out of Mumbai.

Started in May 2017, through Rupam Das, Acculi Labs pursuits to make home-based care to be had to the remaining character at the lowest of the pyramid. It’s flagship product, Lyfas, permits smooth and normal early diagnostics and tracking for early-degree asymptomatic patients even withinside the remotest a part of the sector and allows them to method their doctor at an early degree.

Rupam Das, the CTO and CEO of Acculi Labs, said,

“The funding will be used to carry our vision to reality. [Our] R&D will work with new energy and rigour to simplify healthcare for the needy. [We] will run complete enterprise operations to make sure that Lyfas becomes the need of every household, regardless of geophysical location, as we at Acculi agree with that healthcare is the want of people.”

Acculi Labs additionally obtained investment under the Idea2PoC scheme below the Startup Karnataka coverage and was decided on as one of the top startups of ELEVATE 2018, an initiative of the Department of Information Technology and Biotechnology, Government of Karnataka, which pursuits to offer a complete entrepreneurship platform for startups.

Commenting at the funding, Geetha Mahadevappa, PirE Ventures, said, “We see lots of potential in Lyfas to convert the manner we diagnose and reveal sicknesses today. The asset-light and tech-driven models of the business enterprise are without problems pluggable into numerous setups, along with OPD, telemedicine, and post-surgery care. We believe that collectively PirE and Acculi can redefine virtual health not only for people, however for the nation”.

Earlier, in September 2019, the startup secured undisclosed pre-seed investment from a set of angels and Bengaluru-primarily based consultancy and services company Startup Basket.